Mr. Leonard has been our Chief Executive Officer since December 1, 2025. Prior to being our Chief Executive Officer, Mr. Leonard served President since June 2025. He was responsible for Novocure s global business operations, which he led since January 2024, and was responsible for sales, marketing, field medical affairs, patient experience, public affairs, market access, and product and portfolio strategy functions. Mr. Leonard previously led our US business, beginning in October 2022. Mr. Leonard served as Chief Development Officer of the Company from September 2020 to September 2022, and was responsible for engineering, product development, business development and the overall strategic and operational leadership of our innovation platforms. He joined the Company in 2010 to prepare the company for a commercial launch and held various roles establishing our finance, reimbursement, and business development functions. Prior to joining us, Mr. Leonard was a venture capital investor focused on high-impact medical technology companies, including Novocure. He has served as a director of the Medical Device Manufacturers Association (MDMA) since 2023. Education: A.B. from Harvard University; M.A. from the London School of Economics and Political Science. Other Public Company Directorships: None. We believe that Mr. Leonard is qualified to serve on our Board due to his service as our Chief Executive Officer, President and other roles within our Company and his extensive knowledge of our industry.